1. Home
  2. AAPG vs ACA Comparison

AAPG vs ACA Comparison

Compare AAPG & ACA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • ACA
  • Stock Information
  • Founded
  • AAPG 2009
  • ACA 2018
  • Country
  • AAPG China
  • ACA United States
  • Employees
  • AAPG N/A
  • ACA N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • ACA Metal Fabrications
  • Sector
  • AAPG Health Care
  • ACA Industrials
  • Exchange
  • AAPG Nasdaq
  • ACA Nasdaq
  • Market Cap
  • AAPG 3.6B
  • ACA 4.2B
  • IPO Year
  • AAPG 2025
  • ACA N/A
  • Fundamental
  • Price
  • AAPG $34.61
  • ACA $93.92
  • Analyst Decision
  • AAPG Buy
  • ACA Strong Buy
  • Analyst Count
  • AAPG 1
  • ACA 3
  • Target Price
  • AAPG N/A
  • ACA $112.00
  • AVG Volume (30 Days)
  • AAPG 7.0K
  • ACA 193.0K
  • Earning Date
  • AAPG 11-19-2025
  • ACA 10-30-2025
  • Dividend Yield
  • AAPG N/A
  • ACA 0.21%
  • EPS Growth
  • AAPG N/A
  • ACA N/A
  • EPS
  • AAPG N/A
  • ACA 1.87
  • Revenue
  • AAPG $54,524,554.00
  • ACA $2,675,500,000.00
  • Revenue This Year
  • AAPG N/A
  • ACA $12.65
  • Revenue Next Year
  • AAPG $368.64
  • ACA $6.22
  • P/E Ratio
  • AAPG N/A
  • ACA $50.11
  • Revenue Growth
  • AAPG N/A
  • ACA 9.78
  • 52 Week Low
  • AAPG $16.50
  • ACA $68.11
  • 52 Week High
  • AAPG $48.45
  • ACA $113.43
  • Technical
  • Relative Strength Index (RSI)
  • AAPG 39.44
  • ACA 52.37
  • Support Level
  • AAPG $33.12
  • ACA $91.72
  • Resistance Level
  • AAPG $35.49
  • ACA $95.14
  • Average True Range (ATR)
  • AAPG 0.97
  • ACA 2.37
  • MACD
  • AAPG -0.22
  • ACA 0.29
  • Stochastic Oscillator
  • AAPG 20.89
  • ACA 77.40

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About ACA Arcosa Inc.

Arcosa Inc is a manufacturer and producer of infrastructure-related products and services. It operates in three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment produces and sells construction aggregates and manufactures and sells trench shields and shoring products and services for infrastructure-related projects. The Transportation Products segment manufactures and sells products for the inland waterway and rail transportation industries. The Engineered Structures segment manufactures and sells products for energy-related businesses, including structural wind towers, telecommunication structures, steel utility structures for electricity transmission and distribution, and storage and distribution containers.

Share on Social Networks: